Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a resignation notice from David Guowei Wang, a member of the board of directors (the “Board”) and a member of the Audit Committee, Compensation Committee and the Corporate Governance and Nominating Committee of the Board, effective immediately. Mr. Wang’s resignation was due to increased professional commitments and time constraints and was...
AIDS Healthcare Foundation (AHF), in collaboration with the University of Miami Public Health Policy Lab, will cohost a webinar, “Pandemic Prevention, Preparedness, and Response After the Agreement: What Comes Next?,” on Tuesday, July 8 at 10:00 AM EDT, virtually via Zoom. Register here. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250707205332/en/ This timely webinar will explore the future of global pandemic governance following...
Accellix, a global leader in rapid point of need cytometry solutions, is pleased to announce the appointment of Félix A. Montero-Julian, PhD as Vice President of Scientific Affairs. Dr. Montero-Julian brings more than 30 years of international experience in scientific affairs, analytical development, and regulatory science to support Accellix’s strategic vision and innovation roadmap. Dr. Montero-Julian joins Accellix from bioMérieux, where he most recently served as Scientific Senior Directo...
Icon Solutions, the UK fintech enabling banks globally to design and implement state-of-the-art payment systems, has today announced a new equity investment from UBS. Icon has also secured additional funding from existing investors Citi and NatWest. Pieter Brouwer, Head of Group Operations and Technology Office (GOTO) for Personal & Corporate Banking and GWM Switzerland & International, at UBS comments: “Icon, an important partner of UBS, plays a crucial role in modernizing payment pl...
H.U. Group Holdings Inc., and its wholly owned subsidiary, Fujirebio Holdings, Inc. (hereinafter “Fujirebio”) today announced that Fujirebio Diagnostics, Inc., a subsidiary of Fujirebio, has acquired all shares of Plasma Services Group, Inc. (hereinafter “Plasma Services Group”). The transaction value has not been disclosed. Founded in 2004, Plasma Services Group has specialized in the collection, screening and supply of high quality and rare biological materials required for R&D and manu...